BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2248070)

  • 1. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
    Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
    Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
    Funke HJ; Moritz E; Hellstern K; Malanowski H
    Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
    Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
    Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
    Larsen JK; Gjerris A; Holm P; Anderson J; Bille A; Christensen EM; Høyer E; Jensen H; Mejlhede A; Langagergaard A
    Acta Psychiatr Scand; 1991 Dec; 84(6):564-70. PubMed ID: 1792931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
    Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
    Koczkas C; Holm P; Karlsson A; Nagy A; Ose E; Pétursson H; Ulverås L; Wenedikter O
    Acta Psychiatr Scand; 1989 Jun; 79(6):523-9. PubMed ID: 2669440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
    Lecrubier Y; Pedarriosse AM; Payan C; Schmid-Burgk W; Stabl M
    Acta Psychiatr Scand; 1995 Oct; 92(4):260-5. PubMed ID: 8848950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
    Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK; Holm P; Mikkelsen PL
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
    Gabelic I; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():44-5. PubMed ID: 2248068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
    Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
    Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide (Ro 11-1163) versus tranylcypromine in the treatment of endogenous depression.
    Gabelic I; Kuhn B
    Acta Psychiatr Scand Suppl; 1990; 360():63. PubMed ID: 2248076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.